www.dmd.umn.edu

Keynote Speakers:

• Elizabeth Baron, Director of the VR Lab, Ford Motor Company
• Norman Dann, Innovation Fellows Program, University of Minnesota
• Brian Fitzgerald, Food & Drug Administration (FDA)
• Birali Runesha, Director of Research Computing, University of Chicago
• Matthew Tirrell, PhD, Pritzker Director, Institute for Molecular Engineering, University of Chicago
• Randy Schiestl, VP of R&D, Boston Scientific Corporation

Register Today- Rates Increase after March 27th:
Visit the conference website to view the current program and registration rates. Walk-ins are welcome. Rates increase on-site.

Selected Technical Session Topics for 2012: Live Surgery, Cardiovascular Engineering, Neuroengineering, Micro & Nano Devices, Medical Electronics, Technology Assessment, Design and Human Factors, Orthopedics, Surgical Robotics, Innovation and Design, Tissue Engineering, Medical Technology , Power for Implanted Medical Devices, Rehabilitation Technology, Three-in-Five Competition, Global Health, Virtual Prototyping, Entrepreneurship, FDA Innovation Initiative, Trends in Med Tech Regulation, Neuroendovascular Devices, Laser Therapies

Sponsorship Opportunities: The mission of the Design of Medical Devices conference is to facilitate collaboration between academia and industry. Space is limited. Questions can be directed to Jenny Holden, Conference Administrator at holden@me.umn.edu

New This Year:

• Medical Device Innovation Workshop "Becoming a Medical Technology Innovator", Monday, April 9, 2012
• International Student Design Showcase, Tuesday April 10, 2012
• Symposium: "Virtual Prototyping of Medical Devices", Thursday, April 12, 2012
• ExploraDome-Sponsored by The Minnesota Planetarium, April 10-12, 2012
• Simulation Technologies Suite, April 10-12, 2012

http://acrp2012.org/acrp2012/Public/mainhall.aspx?ID=3523&sortMenu=101000.aspx

The ACRP conference, with the Physicians Program, attracts more than 2,000 clinical research professionals to present, learn and network, providing an invaluable forum for coordinators, associates, monitors, auditors, regulators, nurses, physicians and investigators involved in the clinical research enterprise.

For more information, visit: http://acrp2012.org/acrp2012/Public/mainhall.aspx?ID=3523&sortMenu=101000.aspx

www.healthtech.com/Conferences_Overview.aspx?id=94300&libID=94308

A number of breakthrough technologies are being incorporated into novel diagnostics to detect a range of molecular and protein biomarkers.  The diagnostic methods applied will include PCR, microarrays, sequencing, proteomics, methylation, and mutation detection. This meeting will highlight the next generation of diagnostic platforms that encompass the latest trends in microfluidics, point-of-care technologies, in vivo sensing, and consumer-driven products.  A panel of experts will focus on translation to the medical community and the key to success in implementation.

Topics include: Microfluidic Technology and Business Trends, Point-of-Care Diagnostics, Nanotechnology Advances, Innovation in Microfluidics, In vivo Diagnostic Imaging, and Recent Approvals of Companion Diagnostics

www.bio-itworldexpo.com

Since its debut in 2002, the annual Bio-IT World Conference & Expo has established itself as a premier event showcasing the myriad applications of IT and informatics to biomedical research and the drug discovery enterprise. The 2012 Expo plans to unite 2,000+ life sciences, pharmaceutical, clinical, healthcare, and IT professionals from 30+ countries. Spanning three days, the meeting includes 12 parallel conference tracks and 16 pre-conference workshops. More Information

www.healthtech.com/Strategic-Alliance-Management-Congress/

Cambridge Healthtech Institute’s 9th annual Strategic Alliance Management Congress brings together alliance management, business development, technology transfer and licensing professionals to network and share experiences from their organizations. If your organization is looking for, or is currently working with, Indian or Chinese partners, be sure not to miss the expert presentations on the challenges and rewards of creating alliances overseas.   Identify the key elements of an ailing alliance and the remedies that experts have used to save, renegotiate or end these projects. Discuss the best communication strategies for garnering leadership buy-in for alliance management resources. Network with experts who have a wide range of expertise and experience.  Case studies from successful alliances will be presented throughout the program, complete with representatives from each party, discussing the art and science of managing their alliance.

Reasons to attend: Learn new tools to increase alliance visibility and to gain internal champions for projects, See a new document that can change how your executive management evaluates alliance success, Network and collaborate with industry leaders, Hear case studies from both sides of successful and challenging alliances, current and on-going, and Discuss the challenges facing AM groups in informal roundtable interactive groups.

http://www.smi-online.co.uk/goto/pain-therapeutics55.asp

Pain is the most common reason patients seek medical care and has significant sensory and emotional components. Despite the advances in pain management, few significant advancements have been made, and in recent years it has become harder and harder to get analgesics to market. With the whole industry under financial pressure, there is an economic imperative for companies to improve their research and development methods in order to ensure that drugs being put forward for clinical trials have the best chance of success.

SMi’s 12^th annual Pain Therapeutics conference will allow delegates to hear from industry experts discussing the latest advances in drug development practice and analysing recent case studies of where drugs in the clinical stages have succeeded and failed. This must-attend event will also take an in-depth look at the recent work on current drug targets such as the TRPV family, the Opioid family and Nerve Growth Factor.

Contact Andrew Gibbons: +44 (0)207 827 6156 / agibbons@smi-online.co.uk

www.biomarkerworldcongress.com/

The leading annual meeting dedicated to biomarker research and implementation. The 8th annual Biomarker World Congress includes the following programs: Biomarkers in Drug Development, Molecular Diagnostics, Biomarker Assay Development, and Drug-Diagnostic Co-Development.

For more details on the conference, please contact:
Julia Boguslavsky
Executive Director, Conferences
Cambridge Healthtech Institute
T: 760-732-3139
E: juliab@healthtech.com

www.marcusevansch.com/PCAR_CW

The marcus evans 2nd Global Pharmacovigilance & Adverse Event Reporting Conference will host industry leaders from Pharmaceutical, Biotechnology and Medical Device Companies operating globally as they share best practices, strategies and tools on dissecting the impact of new global regulations, understanding adverse reporting requirements, strengthening data mining and REMS and deploying signal detection tactics.

Attendees will leave this conference with a better understanding of:

1. Current and pending global pharmacovigilance regulations to ensure compliance
2. Robust risk management plans and how to test their effectiveness
3. Data mining techniques to improve decision-making
4. Drug safety strategies from different global markets and industries
5. Internal measures to strengthen drug safety departments

For a $200 discount as a CenterWatch subscriber, please contact Michele Westergaard at Michelew@marcusevansch.com

www.clinicaltrialsummit.com/

The Clinical Trial Oversight Summit features four conferences in one: Mastering Clinical Trial Monitoring, Clinical Quality Risk Management, Clinical Auditing Forum and Vendor Management in Clinical Trials. Join us for over 60 presentations, panel discussions, case studies and dedicated workshops.

Event Short Courses include: Strategies for Source Documentation Verification, Proactive Approaches to Vendor Management, and SOP Assessment: Ensuring GCP Compliance in SOPs

www.cbinet.com/iisgrants

Now in its 5^th year, CBI’s Investigator Initiated Research and Studies Grants Forum brings together professionals from biotechnology, pharmaceutical and medical device companies to explore challenges throughout the lifecycle of an investigator initiated research study. Discover best practices and strategies to streamline grant contracting, FMV determination and trial management while ensuring transparency.

Conference highlights include: Determining strategic goals for your IIS program and promote organizational buy-in, Assessing fair market value (FMV) parameters and understand practical approaches to FMV, Establishing transparency in interactions with HCPs, and Global investigator initiated trials.

For more information or to register, please CBI toll free by phone at 1-800-817-8601 or via e-mail at cbireg@cbinet.com.

www.marcusevansch.com/LSMR_CW

By attending this event, industry leaders will assess the challenges and ongoing needs for information in this ever-changing and uncertain market research industry. With new budget cuts and drugs coming off patent, this is a MUST attend event for those that want to implement innovative approaches towards new research methodologies, techniques, technologies and regulations.

Speakers include: Alexion Pharmaceutical, NPS Pharmaceuticals, Novartis Consumer Health, Shire Pharmaceuticals, Allergan, Auxilium Pharmaceuticals, Baxter International, Inc., Stryker, Millennium Pharmaceuticals, Pfizer, Amgen and many more!

http://www.diahome.org/DIAHOME/FlagshipMeetings/Home.aspx?meetingid=27170

DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. DIA 2012: Collaborate to Innovate is the largest multidisciplinary event that brings together a global network of professionals to foster innovation that will lead to development of safe and effective health care products.

For more information, visit: http://www.diahome.org/DIAHOME/FlagshipMeetings/Home.aspx?meetingid=27170

http://pharmaciconference.com

The Pharma CI Conference & Exhibition (September 11-12, 2012, Parsippany, NJ) is THE INDUSTRY’S GOLD STANDARD for senior level pharmaceutical, biotechnology, medical device and diagnostics professionals seeking the latest news and the rare chance to network with all the industry’s luminaries. More than 300 people came in 2011! This is the biggest and best gathering of pharmaceutical competitive intelligence thought leaders (75+ speakers)!

Join us at this premier gathering and network with other key decision makers as you learn about the most pressing and relevant issues facing the industry today. Enjoy the highest ratio of industry practitioners (pharma, biotech, medical device and diagnostics) of any pharma intelligence conference!

This is the only event featuring a world-class line up of speakers and panelists offering their unique insights and expertise on the topics you care about most! For more information, please go to http://pharmaciconference.com , call 212-228.7974, or email info@pharmaciconference.com.

www.theconferenceforum.org/DisruptiveInnovationsInClinicalTrials-Overview.html

Led by Pfizer and Novartis, this groundbreaking conference delivers only case studies that demonstrate either a disruptive or an innovative approach to advancing clinical trials. Mobile Clinical Trials, Virtual Trials, Open Source Clinical Development are just a few examples of case studies featured.  This conference is designed to be engaging in a highly informative format, similar to the style of TED events. Each session will deliver a clear set of objectives, summary and key take-aways around:

1. Challenges and opportunities in clinical development/trials
2. Innovations in science applied to clinical development/trials
3. Innovations in technology applied to clinical development/trials
4. New business models for clinical development/trials

15% Discount for CenterWatch readers with code CWDP

www.theconferenceforum.org/GlobalClinicalTrials-Overview.html

This strategic level event is focused on how to execute global trials to produce higher quality data at less cost. Led by Purdue Pharma and BMS, key topics include Infrastructure, non-traditional markets, risk management, ethics/corporate responsibility and outsourcing. International regulations and where the clinical, commercial and therapeutic opportunities are outside the US is covered.

15% discount for CenterWatch Readers with code CWGCT

www.theconferenceforum.org/PartnershipOpportunitiesInDrugDelivery-Overview.html

Keynoted by Dr Robert Langer of MIT, this is a strategic level event designed with two purposes:

1. To present a strategic level event for pharma and biotech business development and external licensing professionals with a thorough overview of the latest drug delivery technologies available along with an update on deals and opportunities to enhance patients, therapies and the life cycle of a drug.
2. To provide drug delivery and specialty pharmas with a platform to present their technologies and get the latest insights from both established pharma and biotechs as well as start up companies on what the delivery and formulation needs are.

15% discount for CenterWatch Readers with code CWPOD